Orlando, FL -- (SBWIRE) -- 08/23/2013 -- Hot Stock Profits provides investors and traders with valuable trading tools and content as well as micro-cap stock alerts via eMail and text messages. To Join Our Text Message Alerts Service Just Text The Word Stocks To 555888 From Your Cell Phone. Our Focus Today Is On Vonage Holdings Corp. (NYSE:VG), Opko Health Inc.(NYSE:OPK).
Vonage Holdings Corp. (NYSE:VG) shares decreased 1.09% to $3.17. Sidoti assumed coverage on shares of Vonage Holdings Corp. (NYSE:VG) in a research note issued on August 14. The firm set a “buy” rating on the stock.
Is VG A Strong At The CMP? Get Advantage Of Our Free Trend Analysis Here
Additionally, the company, on July 31, announced results for the second quarter ended June 30, 2013. Net income, excluding adjustments was $12 million or $0.06 per share, down from $21 million or $0.10 per share sequentially and down from $21 million or $0.09 per share in the year ago quarter. GAAP net income was $7 million or $0.04 per share, down from $13 million or $0.06 per share sequentially and up from a net loss of $3 million or $0.01 per share in the year ago period, which included a one-time adjustment of software assets.
Opko Health Inc.(NYSE:OPK) shares fell 0.23% to $8.54. The company on August 15 said it has surpassed 50% enrollment in the second phase 3 trial of Rayaldy™ to treat patients with secondary hyperparathyroidism (SHPT), stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency. This trial is the second of two identical randomized, double-blind, placebo controlled, multi-site studies intended to establish the safety and efficacy of Rayaldy™ as a new treatment for SHPT in the targeted population. The endpoints of both studies, which are being conducted in parallel, include vitamin D status and changes in serum calcium, serum phosphorus and plasma intact parathyroid hormone (PTH).
Is OPK A Good Buy After The Recent Price Movement? Find Out Here
Additionally, the company on August 9 reported operating and financial highlights for the second quarter of 2013. Consolidated revenues more than doubled to $23.8 million during the three months ended June 30, 2013, from $10.2 million in the prior year period and nearly tripled to $55.2 million for the six months ended June 30, 2013, from $19.0 million in the prior year period. Net loss for the three months ended June 30, 2013, was $ 3.4 million, compared to a net loss of $10.8 million for the 2012 period.
Join Our Mobile SMS Alerts By Texting Stocks To 555888
HotStockProfits.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
Disclosure: HotStockProfits.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit HotStockProfits.com website, for complete risks and disclosures.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)